Compare
Modular Medical, Inc. vs SeaStar Medical Holding Corp vs Sonoma Pharmaceuticals, Inc. vs Flyte Aviation, Inc.
| Latest fiscal year | Modular Medical, Inc. MODD | SeaStar Medical Holding Corp ICU | Sonoma Pharmaceuticals, Inc. SNOA | Flyte Aviation, Inc. VJET |
|---|---|---|---|---|
| Year ended | 2026-03-31 | 2025-12-31 | 2026-03-31 | 2025-12-31 |
| Revenue | n/a | $1.23M | $19.53M | $819.0K |
| Revenue growth (YoY) | n/a | +814.1% | +36.7% | +95.0% |
| Gross margin | n/a | 95.7% | 38.0% | 92.3% |
| Operating margin | n/a | -986.6% | -12.6% | n/m |
| Net margin | n/a | -984.6% | -16.3% | n/m |
| Net income | -$28.24M | -$12.15M | -$3.17M | -$17.18M |
| EPS (Diluted) | -$12.36 | n/a | -$1.89 | n/a |
| Operating cash flow | -$23.75M | -$13.60M | -$3.93M | -$8.30M |
| Free cash flow | -$27.68M | n/a | -$4.12M | -$8.31M |
| Cash & equivalents | $6.94M | n/a | $2.40M | $88.0K |
| Total assets | $14.83M | $14.16M | $13.96M | $15.86M |
| Total liabilities | $1.87M | $3.74M | $10.87M | $9.21M |
| Shareholders' equity | $12.96M | $10.42M | $3.10M | $7.05M |
| Return on year-end equity | -217.9% | -116.6% | -102.6% | -243.6% |
| Shares outstanding | 4.66M | 3.84M | 1.80M | 1.74M |
Revenue, most recent five fiscal years
| Fiscal year | Modular Medical, Inc. | SeaStar Medical Holding Corp | Sonoma Pharmaceuticals, Inc. | Flyte Aviation, Inc. |
|---|---|---|---|---|
| Latest | $0 Ended 2018-03-31 | $1.23M Ended 2025-12-31 | $19.53M Ended 2026-03-31 | $819.0K Ended 2025-12-31 |
| 1 year earlier | $0 Ended 2017-03-31 | $135.0K Ended 2024-12-31 | $14.29M Ended 2025-03-31 | $420.0K Ended 2024-12-31 |
| 2 years earlier | n/a | $0 Ended 2023-12-31 | $12.73M Ended 2024-03-31 | $442.0K Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $13.27M Ended 2023-03-31 | $14.0K Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $12.63M Ended 2022-03-31 | $22.0K Ended 2021-12-31 |